(ALT) > Trackbacks

ALTANA AG: ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in the U.S.

Wed, 25 Oct 2006 15:04:00 PDT

BAD HOMBURG/KONSTANZ, GERMANY (MARKET WIRE) ALTANA AG (NYSE: AAA) (FRANKFURT: ALT) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OMNARIS(TM) (Ciclesonide nasal spray), 200µg once-daily.

Trackbacks

A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to ALTANA AG: ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in the U.S..

No trackbacks have been detected.

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.